CH487897A - Process for the preparation of a water-soluble complex of the 8-hydroxy-quinoline - (- sulfonate of 1,5-dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolone - Google Patents
Process for the preparation of a water-soluble complex of the 8-hydroxy-quinoline - (- sulfonate of 1,5-dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazoloneInfo
- Publication number
- CH487897A CH487897A CH701567A CH701567A CH487897A CH 487897 A CH487897 A CH 487897A CH 701567 A CH701567 A CH 701567A CH 701567 A CH701567 A CH 701567A CH 487897 A CH487897 A CH 487897A
- Authority
- CH
- Switzerland
- Prior art keywords
- dimethyl
- isopyrazolone
- quinoline
- sulfonate
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE629650D BE629650A (en) | 1967-05-18 | ||
FR940455A FR2910M (en) | 1967-05-18 | 1963-07-05 | New injectable form of phenyl-1-dimethyl-2,3-dimethylamino-4-pyrazolone-5 ortho-hydroxyquinoline sulfonate useful in influenza and antirhumastimal therapy. |
GB29664/64A GB1072359A (en) | 1967-05-18 | 1964-07-23 | Pyrazolone derivatives and pharmaceutical compositions containing them |
CH701567A CH487897A (en) | 1967-05-18 | 1967-05-18 | Process for the preparation of a water-soluble complex of the 8-hydroxy-quinoline - (- sulfonate of 1,5-dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH701567A CH487897A (en) | 1967-05-18 | 1967-05-18 | Process for the preparation of a water-soluble complex of the 8-hydroxy-quinoline - (- sulfonate of 1,5-dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolone |
Publications (1)
Publication Number | Publication Date |
---|---|
CH487897A true CH487897A (en) | 1970-03-31 |
Family
ID=4318592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH701567A CH487897A (en) | 1967-05-18 | 1967-05-18 | Process for the preparation of a water-soluble complex of the 8-hydroxy-quinoline - (- sulfonate of 1,5-dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolone |
Country Status (4)
Country | Link |
---|---|
BE (1) | BE629650A (en) |
CH (1) | CH487897A (en) |
FR (1) | FR2910M (en) |
GB (1) | GB1072359A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3217315C2 (en) * | 1982-05-08 | 1986-05-22 | Gödecke AG, 1000 Berlin | Medicinal preparations containing oxicam derivatives |
DE3437232A1 (en) * | 1984-10-10 | 1986-04-17 | Mack Chem Pharm | STABILIZED INJECTION SOLUTIONS FROM PIROXICAM |
ITMI20040235A1 (en) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | PHARMACEUTICAL PREPARATION FOR THE ORAL CABLE |
-
0
- BE BE629650D patent/BE629650A/xx unknown
-
1963
- 1963-07-05 FR FR940455A patent/FR2910M/en not_active Expired
-
1964
- 1964-07-23 GB GB29664/64A patent/GB1072359A/en not_active Expired
-
1967
- 1967-05-18 CH CH701567A patent/CH487897A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2910M (en) | 1964-11-09 |
GB1072359A (en) | 1967-06-14 |
BE629650A (en) | 1900-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH481110A (en) | Process for the preparation of 1,2,4,5-tetrahydro-3-azepines | |
CH480410A (en) | Process for the preparation of water-soluble azopyrimidine dyes | |
CH518953A (en) | Process for the preparation of 2-methyl-3-carboxylic acid-amidoquinoxaline-di-N-oxides- (1,4) | |
CH512499A (en) | Process for the preparation of 2-halomethyl-3-carboxamido-quinoxaline-di-N-oxides- (1,4) | |
CH523264A (en) | Process for the preparation of 2,4 benzdiazepines | |
CH506537A (en) | Process for the preparation of 2-isothiuroniummethyl-3-carboxamido-quinoxaline-di-N-oxide (1,4) -halides | |
CH487897A (en) | Process for the preparation of a water-soluble complex of the 8-hydroxy-quinoline - (- sulfonate of 1,5-dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolone | |
CH497480A (en) | Process for the preparation of poly-B-propiolactones disubstituted in the a positions | |
CH465095A (en) | Process for the preparation of a water-soluble 1: 1 azo dye-chromium complex | |
AT289295B (en) | Process for the preparation of water-soluble salts of α-aminobenzylpenicilin | |
CH471782A (en) | Process for the preparation of a new, substituted 2,3-pyridinediol | |
CH493552A (en) | Process for the preparation of 3-oxo-5-chloro-1,2,4-thiadiazolinium salts | |
CH524563A (en) | Process for the preparation of 3,5-di-lower alkoxy-homophthalic acids | |
CH479544A (en) | Process for the preparation of 2,5-diamino-3,6-dihalo-p-benzoquinones | |
CH495999A (en) | Process for the preparation of 1,4,9,10-tetrahydro-benzo- (5,6) cycloheptal (1,2-d) imidazol-4-ones | |
AT281318B (en) | Process for the preparation of 3,5-dioxo-4,5-seco-13β-R-17α-ethinyl-17β-hydroxygona-9-enes | |
CH484932A (en) | Process for the preparation of 1,2-benzisothiazoles | |
CH507891A (en) | Process for the preparation of derivatives of 3,7-dimethyl-2,7-3ctadien-1-al | |
AT281022B (en) | Process for the preparation of 1-n-butyl-2 ', 6'-pipecoloxylidide | |
AT291967B (en) | Process for the preparation of new N-phenyl-N-2-fluoro-1,1,2,2, -tetrachloroethylsulfenyl-sulfamides | |
CH507210A (en) | Process for the preparation of 2,3-dihaloacrylanilides | |
CH516566A (en) | Process for the preparation of 2,4-dihydroxy-5-aminomethyl-6-methylpyrimidines | |
CH513185A (en) | Process for the preparation of 3-carboxamidoquinoxaline-di-N-oxides- (1.4) | |
AT286272B (en) | Process for the preparation of 2,6-dichlorobenzamide | |
DD67023A1 (en) | Process for the preparation of a tea comprim |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |